We are the Rimidi.

Bill has spent his career advising corporate clients, organizations, and governmental entities on legal, regulatory, and business matters. Bill is an expert in corporate governance. He formerly served as Senior Vice President and General Counsel of Monsanto Company, President of the American Bar Association, Counsel to the United States Olympic Committee, and on the Board of Albemarle Corporation. Currently, Bill serves as a member of the Board of AFC Enterprises, chair of the Advisory Board to the Conference Board’s Governance Center, Senior Fellow and Co-Founder of Emory University’s Directors Institute, and a member of the Clark Atlanta University Board of Trustees. He is General Counsel and Secretary of the EastWest Institute, a global think-and-do tank. Bill is an experienced investor in early stage companies.

Lucie brings her diverse experiences in medicine, science, venture capital and technology to bear in leading Rimidi’s strategy and vision. Motivated by the belief that we can do so much better as individuals, an industry and society, Lucie left clinical medicine to join the ranks of healthcare entrepreneurs who are trying to revolutionize an industry.

Bob is an investor and advisor to high tech companies. He has 24 years of management experience in high-technology enterprises. He served as an officer at Wang Laboratories, contributing to growth in revenue from $50 million to $2.7 billion, and is the founder of two successful high-tech businesses (Library Systems and Bozemans’, Inc.). Bob was a General Partner with Ron Conway and Casey McGlynn in Angel Investors, LP for both Fund I and Fund II, which invested in technology companies including Ask Jeeves, AvantGo, BrightMail, Chemdex/Ventro, FindLaw, Good Technology, Google, MongoMusic, OpenTable, Opsware/LoudCloud, PayPal, RedEnvelope and Vovida Networks. Bob currently is currently General Partner of Eastlake Ventures and 530 Angels. He also serves on the Board of the public company Daegis based in Dallas.

Dr. Braunstein teaches health informatics as a graduate seminar in the college and as an elective in the Online Masters of Science in Computer Science (OMSCS) program. His latest book, Practitioners Guide to Health Informatics, a guide to health informatics for physicians and other non-technical readers, was published in the spring of 2015. His text, Contemporary Health Informatics, was published in the spring of 2014. Health Informatics in the Cloud, a brief guide to health informatics for non-technical readers, was published in 2012.

David Byrne is a lawyer by training and before entering public life spent 30 years practicing as a Barrister in the Courts of Ireland and the European Court of Justice in Luxemburg. In 1997 he was appointed Attorney General of Ireland (AG). During his term of office as AG, he was one of the negotiators of the Good Friday Agreement, which provided the political and legal framework for peace in Northern Ireland. He drafted and managed the constitutional changes necessary to give effect to the new Agreement, which were adopted by a referendum of the people in 1998

View David’s complete profile on Wikipedia.

Greg Hunter is a Winston-Salem, NC based businessman with an international reach in the areas of real estate, energy, hospitality, and functional beverages. Since the early 1990’s, Mr. Hunter has been involved in global asset management consulting, working with large pools of capital to effectively deploy their funds across a wide variety of strategies. More recently, he has begun to integrate the business strategies of foreign companies with US companies to promote global commerce. Additionally, he is aggregating real estate portfolios in the US, developing select properties across a variety of asset classes. Mr. Hunter serves on numerous not-for-profit and for profit boards.

Dr. Heval Mohamed Kelli came to the US as a teenage refugee from Syria and worked as dishwasher for years to support his family and education. He is currently named the prestigious Katz foundation Fellow in Preventive Cardiology in the Emory University department of medicine. He graduated Cum Laude from Morehouse School of Medicine and he finished his internal medicine residency training with honorable distinctions in social and inpatient medicine at Emory University. Dr. Mohamed Kelli was voted resident of the year by his colleagues at Emory University in 2013. He operates several non-profit organizations focused on mentorship, healthcare outreach and medical education. His remarkable journey and story was featured on the Emory University magazine, Associated Press, NY times, CNN and Washington Post

Olivier leverages 30 years of passion improving health and living standards throughout Western/Eastern Europe, the Americas and Asia to create sustainable, profitable growth, organically and inorganically, in the Life Sciences, Consumer Health, Nutrition and Consulting industries. He assembles talented, successful and diverse teams to address unique business or societal challenges.

In 2009, when the H1N1 global pandemic flu spread globally, he redirected his team to address the needs of governments in Western and Eastern Europe. They closed the first sale for Novartis (several hundred million Euros) followed by several other ones throughout Europe and Russia/CIS.